Financials
- Market Capitalization 1.86 B
- Employee 161
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-33.72
市销率
10.53
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2014 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.51 USD | +2.46% | +5.36% | +33.71% | +107.95% | 1.92 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 39.15 USD | -2.30% | -3.69% | +5.24% | +629.05% | 1.90 B USD | ||
| 2044 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.15 USD | -2.63% | -4.41% | +28.36% | +94.94% | 1.85 B USD | ||
| 2051 | PGEN Precigen, Inc. - Common Stock | 5.17 USD | -2.82% | -8.17% | +12.39% | +163.78% | 1.84 B USD |